Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Net Margin (2023 - 2025)

Mangoceuticals' Net Margin history spans 3 years, with the latest figure at 3246.68% for Q4 2025.

  • On a quarterly basis, Net Margin fell 139546.0% to 3246.68% in Q4 2025 year-over-year; TTM through Dec 2025 was 4655.73%, a 319430.0% decrease, with the full-year FY2025 number at 4784.65%, down 324078.0% from a year prior.
  • Net Margin hit 3246.68% in Q4 2025 for Mangoceuticals, up from 9391.8% in the prior quarter.
  • Over the last five years, Net Margin for MGRX hit a ceiling of 733.99% in Q3 2023 and a floor of 9391.8% in Q3 2025.
  • Historically, Net Margin has averaged 2697.86% across 3 years, with a median of 1785.35% in 2024.
  • Biggest five-year swings in Net Margin: surged 143666bps in 2024 and later plummeted -767232bps in 2025.
  • Tracing MGRX's Net Margin over 3 years: stood at 1050.87% in 2023, then crashed by -76bps to 1851.22% in 2024, then crashed by -75bps to 3246.68% in 2025.
  • Business Quant data shows Net Margin for MGRX at 3246.68% in Q4 2025, 9391.8% in Q3 2025, and 3221.61% in Q2 2025.